Literature DB >> 7775260

Do structural changes of T cell receptor complex occur in tumor-bearing state?

S Noda1, T Nagata-Narumiya, A Kosugi, S Narumiya, C Ra, H Fujiwara, T Hamaoka.   

Abstract

T cells in tumor-bearing mice and cancer patients were recently shown to be devoid of CD3-zeta chain, a signal-transducing invariant chain in T cell receptor (TCR) complex, and p56lck tyrosine kinase. In the present study, we investigated the structure and function of TCR complex in T cells from BALB/c mice bearing CSA1M fibrosarcoma. The expressions of TCR chains and p56lck in a T cell-enriched population from spleen were analyzed. Almost complete loss of CD3-zeta and p56lck was observed in the preparation from tumor-bearing mice as assessed by immunoblotting analysis using whole cell lysates, whereas the amounts of other TCR chains were relatively unchanged. However, these changes were due to the increase of contaminating Mac-1+ cells in the spleen of tumor-bearing mice because: 1) the removal of Mac-1+ cells led to the restoration of CD3-zeta and p56lck; and 2) CD3-zeta was clearly present when the preparation was solubilized with ionic detergent. Fc receptor gamma chain detected in the preparation from tumor-bearing mice disappeared along with the removal of Mac-1+ cells. These observations were further supported by the finding that addition of Mac-1+ cells from tumor-bearing mice to normal T cells resulted in loss of CD3-zeta, leaving CD3-epsilon largely intact. When T cells from tumor-bearing mice were highly purified by depletion of Mac-1+ cells, these T cells contained normal amounts of CD3-zeta at mRNA, protein, and surface levels, and expressed the properly assembled TCR complex on their cell surface. Moreover, stimulation of the TCR in these T cells by anti-TCR antibodies resulted in a comparable Ca2+ mobilization to that observed in normal T cells. These results suggest that no structural changes occur in TCR complex in our tumor-bearing mice, and that complete depletion of Mac-1+ cells in important to assess the structure of TCR complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775260      PMCID: PMC5920829          DOI: 10.1111/j.1349-7006.1995.tb03068.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


antigen‐presenting cell T cell receptor flow cytometry fluo‐rescein isothiocyanate sodium dodecyl sulfate polyacrylamide gel electrophoresis Fc receptor Fc receptor type I for IgE complement activated complement phosphate‐buffered saline bovine serum albumin antibody, mAb, monoclonal antibody
  41 in total

Review 1.  Suppressor cells: permitters and promoters of malignancy?

Authors:  D Naor
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

2.  Instability of assembled T-cell receptor complex that is associated with rapid degradation of zeta chains in immature CD4+CD8+ thymocytes.

Authors:  A Kosugi; A M Weissman; M Ogata; T Hamaoka; H Fujiwara
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice.

Authors:  T Sakata; S Iwagami; Y Tsuruta; H Teraoka; S Suzuki; R Suzuki
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

Review 4.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  TCR isoform containing the Fc receptor gamma chain exhibits structural and functional differences from isoform containing CD3 zeta.

Authors:  H Ohno; T Aoe; C Ra; T Yamamoto; T Saito
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

6.  Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

Authors:  H Nakagomi; M Petersson; I Magnusson; C Juhlin; M Matsuda; H Mellstedt; J L Taupin; E Vivier; P Anderson; R Kiessling
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

7.  T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

Authors:  E S Dye; R J North
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

8.  Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly.

Authors:  J S Bonifacino; C K Suzuki; J Lippincott-Schwartz; A M Weissman; R D Klausner
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

9.  T cell development in mice lacking the CD3-zeta/eta gene.

Authors:  M Malissen; A Gillet; B Rocha; J Trucy; E Vivier; C Boyer; F Köntgen; N Brun; G Mazza; E Spanopoulou
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

10.  Preferential usage of the Fc receptor gamma chain in the T cell antigen receptor complex by gamma/delta T cells localized in epithelia.

Authors:  H Ohno; S Ono; N Hirayama; S Shimada; T Saito
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  6 in total

1.  A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods.

Authors:  A M Deakin; K Singh; J S Crowe; J H Ellis; A Dalgleish; R J Leicester; C J Finlayson; W F Miles; P F Life
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Subunit composition of the pre-T-cell receptor complex analysed by monoclonal antibody against the pre-T-cell receptor alpha chain.

Authors:  A Kosugi; S Noda; S Saitoh; S Narumiya; M Ogata; Y Hashimoto; K Takase; T Saito; T Hamaoka
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

3.  Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

Authors:  Srinivas Nagaraj; Adam G Schrum; Hyun-Il Cho; Esteban Celis; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

4.  Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease.

Authors:  Shin Saitoh; Satoshi Noda; Yuji Aiba; Atsushi Takagi; Mitsuo Sakamoto; Yoshimi Benno; Yasuhiro Koga
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

5.  Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses.

Authors:  M Otsuji; Y Kimura; T Aoe; Y Okamoto; T Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  T cell avidity and tumor recognition: implications and therapeutic strategies.

Authors:  Mark D McKee; Jeffrey J Roszkowski; Michael I Nishimura
Journal:  J Transl Med       Date:  2005-09-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.